Leap Therapeutics, Inc. (LPTX) Total Assets by Year
Leap Therapeutics, Inc. closed fiscal year 2025 with $163.2M in total assets, $9.7M in total liabilities and $153.5M in shareholder equity. This represents an increase of 232.2% from the prior fiscal year. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Leap Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
LPTX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $163.2M+232.2% | $49.1M-32.5% | $72.8M+3.5% | $70.4M-40.3% | $117.9M+116.9% | $54.4M+630.0% | $7.4M-61.0% | $19.1M-34.4% | $29.1M+350.1% | $6.5M |
| Total Liabilities | $9.7M-31.3% | $14.1M+11.0% | $12.7M+10.4% | $11.5M+14.6% | $10.0M+29.8% | $7.7M-16.1% | $9.2M-7.1% | $9.9M-44.8% | $17.9M-83.2% | $106.7M |
| Total Equity | $153.5M+338.0% | $35.0M-41.7% | $60.1M+2.2% | $58.9M-45.4% | $107.9M+131.3% | $46.7M+2767.3% | -$1.7M-119.1% | $9.2M-17.5% | $11.1M+111.1% | -$100.2M |
LPTX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'24 | Q4'23 | Q3'23 | Q2'23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $87.4M+150.5% | $163.2M+232.2% | $11.4M-82.5% | $20.0M-75.4% | $34.9M-39.8% | $49.1M-32.5% | $65.0M-21.7% | $81.4M-15.1% | $58.0M-45.6% | $72.8M+3.5% | $83.0M+1.1% | $95.9M+1.8% |
| Total Liabilities | $3.0M-78.6% | $9.7M-31.3% | $8.7M-45.9% | $14.3M-8.4% | $14.0M+32.6% | $14.1M+11.0% | $16.1M+45.8% | $15.6M+32.5% | $10.6M-86.5% | $12.7M+10.4% | $11.0M-8.7% | $11.8M+8.4% |
| Total Equity | $84.4M+304.9% | $153.5M+338.0% | $2.7M-94.5% | $5.7M-91.3% | $20.8M-56.0% | $35.0M-41.7% | $49.0M-32.0% | $65.8M-21.7% | $47.4M+67.2% | $60.1M+2.2% | $72.0M+2.8% | $84.1M+0.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Leap Therapeutics, Inc. financials
Frequently Asked Questions
What was Leap Therapeutics, Inc.'s total assets in fiscal year 2025?
Leap Therapeutics, Inc. closed fiscal year 2025 with $163.2M in total assets, $9.7M in total liabilities and $153.5M in shareholder equity.
How fast is Leap Therapeutics, Inc.'s total assets growing?
Leap Therapeutics, Inc. (LPTX) total assets rose by 232.2% year over year, from $49.1M to $163.2M in fiscal year 2025.
How has Leap Therapeutics, Inc.'s total assets changed over the years?
Across the 10 fiscal years this page covers, Leap Therapeutics, Inc. (LPTX) total assets went from $6.5M in fiscal year 2016 to $163.2M in fiscal year 2025.
What was Leap Therapeutics, Inc.'s total assets in the most recent quarter?
Leap Therapeutics, Inc. (LPTX) reported $87.4M in total assets in Q1 2026. This represents an increase of 150.5% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Leap Therapeutics, Inc. (LPTX) reported on that line in every period on record.